These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. A cascade model for restenosis. A special case of atherosclerosis progression. Libby P; Schwartz D; Brogi E; Tanaka H; Clinton SK Circulation; 1992 Dec; 86(6 Suppl):III47-52. PubMed ID: 1424051 [TBL] [Abstract][Full Text] [Related]
8. Morphological observations late (greater than 30 days) after clinically successful coronary balloon angioplasty. Waller BF; Pinkerton CA; Orr CM; Slack JD; VanTassel JW; Peters T Circulation; 1991 Feb; 83(2 Suppl):I28-41. PubMed ID: 1991400 [TBL] [Abstract][Full Text] [Related]
9. Temporal expression of c-fos mRNA following balloon injury in the rat common carotid artery. Mills CJ; Northrup JL; Hullinger TG; Simmons CA; Shebuski RJ; Jones DA Cardiovasc Res; 1996 Nov; 32(5):954-61. PubMed ID: 8944827 [TBL] [Abstract][Full Text] [Related]
11. [Treatment of intimal hyperplasia by gene therapy: an update]. Reis E; Martinet O; Mosimann F J Mal Vasc; 1999 Dec; 24(5):349-55. PubMed ID: 10642646 [TBL] [Abstract][Full Text] [Related]
12. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque. Kowalski M J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863 [TBL] [Abstract][Full Text] [Related]
13. Expression of polymorphonuclear leukocyte adhesion molecules and its clinical significance in patients treated with percutaneous transluminal coronary angioplasty. Inoue T; Sakai Y; Morooka S; Hayashi T; Takayanagi K; Takabatake Y J Am Coll Cardiol; 1996 Nov; 28(5):1127-33. PubMed ID: 8890805 [TBL] [Abstract][Full Text] [Related]
14. In situ detection of platelet-derived growth factor-A and -B chain mRNA in human coronary arteries after percutaneous transluminal coronary angioplasty. Ueda M; Becker AE; Kasayuki N; Kojima A; Morita Y; Tanaka S Am J Pathol; 1996 Sep; 149(3):831-43. PubMed ID: 8780387 [TBL] [Abstract][Full Text] [Related]
15. Deposition of PG-M/versican is a major cause of human coronary restenosis after percutaneous transluminal coronary angioplasty. Matsuura R; Isaka N; Imanaka-Yoshida K; Yoshida T; Sakakura T; Nakano T J Pathol; 1996 Nov; 180(3):311-6. PubMed ID: 8958811 [TBL] [Abstract][Full Text] [Related]
16. Growth-arrest homeobox gene Gax: a molecular strategy to prevent arterial restenosis. Maillard L; Walsh K Schweiz Med Wochenschr; 1996 Oct; 126(41):1721-6. PubMed ID: 8893412 [TBL] [Abstract][Full Text] [Related]
17. The intron 6 G/T polymorphism of c-myb oncogene and the risk for coronary in-stent restenosis. Gross CM; Krämer J; Pfeufer A; Dietz R; Gessner R; Praus M Basic Res Cardiol; 2004 Jul; 99(4):309-14. PubMed ID: 15221349 [TBL] [Abstract][Full Text] [Related]
18. Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: phase II results of the Kuopio Angiogenesis Trial (KAT). Hedman M; Hartikainen J; Syvänne M; Stjernvall J; Hedman A; Kivelä A; Vanninen E; Mussalo H; Kauppila E; Simula S; Närvänen O; Rantala A; Peuhkurinen K; Nieminen MS; Laakso M; Ylä-Herttuala S Circulation; 2003 Jun; 107(21):2677-83. PubMed ID: 12742981 [TBL] [Abstract][Full Text] [Related]
19. [Mechanisms and prevention of restenosis after coronary angioplasty]. Drechsel S; Bertel O; Lafont A Schweiz Med Wochenschr; 1998 Mar; 128(13):497-507. PubMed ID: 9583101 [TBL] [Abstract][Full Text] [Related]
20. [Coronary circulation-derived plasma in patients with vascular restenosis stimulates the growth of coronary artery smooth muscle cells in culture]. Okamoto Y; Uemura S; Yamamoto H; Dohi K; Nakano H Rinsho Byori; 1997 Oct; 45(10):1008-12. PubMed ID: 9369081 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]